Bjarne Kveim Lie - The status at growth stage, Eur 5B committed, 140 investments, Growth > FCF, Dr Alban and the asymmetric risk-reward ratio

Bjarne Kveim Lie - Managing Partner and Chief Investment Officer at Verdane.

Verdane invests in technology companies with equity tickets between 8 and 150m Euro, they have Eur 5B of committed capital and over 140 investments since 2003. They have a flexible mandate and can make both minority and majority investments. In addition to making individual investments they also act as a solution provider for GPs that seek liquidity and have completed over 50 so called ‘secondary directs’ over the years.

They have been named Best European PE Growth Fund all the years between 2019 and 2023 and Best European mid-market PE fund in 2022.

During this episode we discuss about the status of the growth stage as an asset class, the learnings from investing for over 20 years and the fun parallel between investing with an asymmetric risk reward ratio and Dr Alban. It’s my life!